QUALIGEN THERAPEUTICS INC
COM · CUSIP 74754R103
0
institutional holders
-31 vs Q3 2022
—reported value*
0 new
0 added
0 reduced
31 sold out
net sold ≈ $622.0k (-2.3m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q4 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 31 |
| Q4 2022 | 0 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
CallsPuts
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2022 | $13.0k | $0 | 0.00 |
| Q4 2022 | $0 | $0 | — |
Biggest buyers
| None |
Biggest sellers
| VANGUARD GROUP INC | Sold out | -1.0m |
| BlackRock Inc. | Sold out | -258.4k |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -226.7k |
| PRICE T ROWE ASSOCIATES INC /MD/ | Sold out | -128.9k |
| STATE STREET CORP | Sold out | -109.3k |
| COMMONWEALTH EQUITY SERVICES, LLC | Sold out | -90.5k |
| HighMark Wealth Management LLC | Sold out | -80.1k |
| UBS Group AG | Sold out | -56.8k |
| FRANKLIN RESOURCES INC | Sold out | -55.4k |
| Raymond James Financial Services Advisors, Inc. | Sold out | -48.6k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
FARADAY FUTURE INTELLIGENT ELECTRIC INC.
13D · may seek influence
+12.0 pts · filed 2025-11-19
Stated purposeThe Reporting Person is filing this First Amendment to report that it has acquired beneficial ownership of shares of Common Stock issuable upon the conversion of shares of Series B Preferred Stock that were purchased pursuant to the Subscription Agreement but which were not convertible until the receipt of the approval of the Issuer's stockholders, which approval was obtained on November 12, 2025, as reported on the Issuer's Form 8-K filed with the Securities and Exchange Commission on November 17, 2025. The Reporting Person may, from time to time, depending on prevailing market, economic and other conditions, acquire additional shares of Common Stock or other securities of the Issuer, dispose of any such securities, or engage in discussions with the Issuer concerning such acquisitions or … Full filing |
20.0% |
Holders, Q4 2022
| Manager | Shares | Change |
|---|